Strumento inattivo

Azioni Abaco Capital PLC

Azioni

Durata

Periodo

Stile

Oxford Pharmascience : Completion of Demerger, Board Changes & Change of Company Name to Abaco Capital plc	21/12/17
Oxford Pharmascience : Confirmation of Capital Reductions	19/12/17
Oxford Pharmascience : Subdivision of Capital	04/12/17
Oxford Pharmascience : FDA Pre-IND Advice on OXPzero™ Ibuprofen OTC Opportunity	29/11/17
Oxford Pharmascience : Result of General Meeting	27/11/17

Settore

	Variaz. 1 gen.	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+200,06%	7,18 Mrd
CHURCHILL CAPITAL CORP VII	+2,10%	982 Mln
APPLE ISPORTS GROUP, INC.	+41,91%	872 Mln
PERELLA WEINBERG PARTNERS	+23,30%	806 Mln
ARES ACQUISITION CORPORATION II	+1,74%	664 Mln
E7 GROUP	+5,92%	642 Mln
DA ZHONG TRADING GROUP HOLDING COMPANY	+0,00%	600 Mln
ADMIRAL ACQUISITION LIMITED	+3,61%	503 Mln
CAPITOL INVESTMENT CORP. VII	-.--%	500 Mln